Difference between revisions of "CNS5:Volunteer Assignments and Opportunities"
Jump to navigation
Jump to search
[checked revision] | [checked revision] |
(14 intermediate revisions by 2 users not shown) | |||
Line 16: | Line 16: | ||
!'''Date of Last Editor Review''' | !'''Date of Last Editor Review''' | ||
!'''Notes''' | !'''Notes''' | ||
+ | |- | ||
+ | |CHAPTER 2 (GLIOMAS, GLIONEURONAL TUMOURS, AND NEURONAL TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[CNS5:Astrocytoma,_IDH-mutant|Astrocytoma, IDH-mutant]] | |[[CNS5:Astrocytoma,_IDH-mutant|Astrocytoma, IDH-mutant]] | ||
Line 48: | Line 68: | ||
|LS | |LS | ||
| | | | ||
− | |Moved from " | + | |Moved from "Glioblastoma, IDH-wildtype" to new page; 2021 template added |
|- | |- | ||
|[[CNS5:Diffuse_astrocytoma,_MYB-_or_MYBL1-altered|Diffuse astrocytoma, MYB- or MYBL1-altered]] | |[[CNS5:Diffuse_astrocytoma,_MYB-_or_MYBL1-altered|Diffuse astrocytoma, MYB- or MYBL1-altered]] | ||
Line 55: | Line 75: | ||
|6/27/2023 | |6/27/2023 | ||
| | | | ||
− | | | + | |COMPLETE |
| | | | ||
|LS | |LS | ||
Line 85: | Line 105: | ||
|[[CNS5:Diffuse_low-grade_glioma,_MAPK_pathway-altered_|Diffuse low-grade glioma, MAPK pathway-altered]] | |[[CNS5:Diffuse_low-grade_glioma,_MAPK_pathway-altered_|Diffuse low-grade glioma, MAPK pathway-altered]] | ||
|Disease | |Disease | ||
+ | |Scott Smith | ||
+ | |5/3/2024 | ||
| | | | ||
+ | |PENDING | ||
| | | | ||
− | | | + | |LS |
− | |||
− | |||
− | |||
| | | | ||
| | | | ||
Line 136: | Line 156: | ||
| | | | ||
| | | | ||
− | | | + | | |
|- | |- | ||
|[[CNS5:Pilocytic_astrocytoma_|Pilocytic astrocytoma]] | |[[CNS5:Pilocytic_astrocytoma_|Pilocytic astrocytoma]] | ||
Line 467: | Line 487: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 3 (CHOROID PLEXUS TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[CNS5:Choroid_plexus_papilloma|Choroid plexus papilloma]] | |[[CNS5:Choroid_plexus_papilloma|Choroid plexus papilloma]] | ||
Line 500: | Line 540: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 4 (EMBRYONAL TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[CNS5:Medulloblastoma,_WNT-activated|Medulloblastoma, WNT-activated]] | |[[CNS5:Medulloblastoma,_WNT-activated|Medulloblastoma, WNT-activated]] | ||
Line 621: | Line 681: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 5 (PINEAL TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[CNS5:Pineocytoma|Pineocytoma]] | |[[CNS5:Pineocytoma|Pineocytoma]] | ||
Line 676: | Line 756: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 6 (CRANIAL AND PARASPINAL NERVE TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[CNS5:Schwannoma|Schwannoma]] | |[[CNS5:Schwannoma|Schwannoma]] | ||
Line 753: | Line 853: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 7 (MENINGIOMA) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[CNS5:Meningioma|Meningioma]] | |[[CNS5:Meningioma|Meningioma]] | ||
Line 764: | Line 884: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 8 (MESENCHYMAL, NON-MENINGOTHELIAL TUMOURS INVOLVING THE CNS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[CNS5:Solitary_fibrous_tumour|Solitary fibrous tumour]] | |[[CNS5:Solitary_fibrous_tumour|Solitary fibrous tumour]] | ||
Line 885: | Line 1,025: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 9 (MELANOCYTIC TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[CNS5:Diffuse_meningeal_melanocytic_neoplasms:_Melanocytosis_and_melanomatosis|Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis]] | |[[CNS5:Diffuse_meningeal_melanocytic_neoplasms:_Melanocytosis_and_melanomatosis|Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis]] | ||
Line 907: | Line 1,067: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 10 (HAEMATOLYMPHOID TUMOURS INVOLVING THE CNS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[CNS5:Primary_diffuse_large_B-cell_lymphoma_of_the_CNS|Primary diffuse large B-cell lymphoma of the CNS]] | |[[CNS5:Primary_diffuse_large_B-cell_lymphoma_of_the_CNS|Primary diffuse large B-cell lymphoma of the CNS]] | ||
Line 983: | Line 1,163: | ||
|MS | |MS | ||
| | | | ||
− | |2021 template added | + | |2021 template added; Did not yet convert to CNS5 namespace. Should Jennie instead do the related two pages in HAEM5 of "[[HAEM5:ALK-positive anaplastic large cell lymphoma|ALK-positive anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)]]" and "[[HAEM5:ALK-negative anaplastic large cell lymphoma|ALK-negative anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)]]"? |
|- | |- | ||
|[[CNS5:T-cell_and_NK/T-cell_lymphomas|T-cell and NK/T-cell lymphomas]] | |[[CNS5:T-cell_and_NK/T-cell_lymphomas|T-cell and NK/T-cell lymphomas]] | ||
Line 1,051: | Line 1,231: | ||
| | | | ||
|- | |- | ||
− | | | + | |CHAPTER 11 (GERM CELL TUMOURS) |
− | + | | | |
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
|- | |- | ||
− | |[[CNS5: | + | |[[CNS5:Germ_cell_tumours_of_the_CNS|Germ cell tumours of the CNS]] |
|Disease | |Disease | ||
| | | | ||
Line 1,073: | Line 1,262: | ||
| | | | ||
|- | |- | ||
− | | | + | |CHAPTER 12 (TUMOURS OF THE SELLAR REGION |
− | + | | | |
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
|- | |- | ||
− | |[[CNS5: | + | |[[CNS5:Adamantinomatous_craniopharyngioma|Adamantinomatous craniopharyngioma]] |
|Disease | |Disease | ||
| | | | ||
Line 1,095: | Line 1,293: | ||
| | | | ||
|- | |- | ||
− | |[[CNS5: | + | |[[CNS5:Papillary_craniopharyngioma|Papillary craniopharyngioma]] |
|Disease | |Disease | ||
| | | | ||
Line 1,106: | Line 1,304: | ||
| | | | ||
|- | |- | ||
− | |[[CNS5: | + | |[[CNS5:Pituicytoma,_granular_cell_tumour_of_the_sellar_region,_and_spindle_cell_oncocytoma|Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma]] |
|Disease | |Disease | ||
| | | | ||
Line 1,117: | Line 1,315: | ||
| | | | ||
|- | |- | ||
− | |[[CNS5: | + | |[[CNS5:Pituitary_adenoma_/_pituitary_neuroendocrine_tumour|Pituitary adenoma / pituitary neuroendocrine tumour]] |
|Disease | |Disease | ||
| | | | ||
Line 1,128: | Line 1,326: | ||
| | | | ||
|- | |- | ||
− | |[[CNS5: | + | |[[CNS5:Pituitary_blastoma|Pituitary blastoma]] |
|Disease | |Disease | ||
| | | | ||
Line 1,139: | Line 1,337: | ||
| | | | ||
|- | |- | ||
− | | | + | |CHAPTER 13 (METASTASES TO THE CNS) |
− | | | + | | |
− | | | + | ---- |
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
− | + | ---- | |
|- | |- | ||
− | |[[CNS5: | + | |[[CNS5:Metastases_to_the_brain_and_spinal_cord_parenchyma|Metastases to the brain and spinal cord parenchyma]] |
|Disease | |Disease | ||
| | | | ||
Line 1,161: | Line 1,368: | ||
| | | | ||
|- | |- | ||
− | |[[CNS5: | + | |[[CNS5:Metastases_to_the_meninges|Metastases to the meninges]] |
|Disease | |Disease | ||
| | | | ||
Line 1,172: | Line 1,379: | ||
| | | | ||
|- | |- | ||
− | | | + | |CHAPTER 14 (GENETIC TUMOUR SYNDROMES INVOLVING THE CNS) |
− | + | | | |
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
|- | |- | ||
− | |[[CNS5: | + | |[[CNS5:Neurofibromatosis_type_1|Neurofibromatosis type 1]] |
+ | |Disease | ||
+ | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |- | ||
+ | |[[CNS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]] | ||
+ | |Disease | ||
+ | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |- | ||
+ | |[[CNS5:Schwannomatosis|Schwannomatosis]] | ||
|Disease | |Disease | ||
| | | | ||
Line 1,194: | Line 1,432: | ||
| | | | ||
|- | |- | ||
− | |[[CNS5: | + | |[[CNS5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]] |
+ | |Disease | ||
+ | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |- | ||
+ | |[[CNS5:Tuberous_sclerosis|Tuberous sclerosis]] | ||
|Disease | |Disease | ||
| | | | ||
Line 1,204: | Line 1,453: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |[[CNS5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]] | ||
+ | |Disease | ||
+ | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
|- | |- | ||
|[[CNS5:Cowden_syndrome|Cowden syndrome]] | |[[CNS5:Cowden_syndrome|Cowden syndrome]] | ||
|Disease | |Disease | ||
− | | | + | |[[DIG5:Volunteer Assignments and Opportunities|See DIG5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
|- | |- | ||
|[[CNS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]] | |[[CNS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]] | ||
|Disease | |Disease | ||
− | | | + | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
|- | |- | ||
|[[CNS5:Familial_adenomatous_polyposis_1|Familial adenomatous polyposis 1]] | |[[CNS5:Familial_adenomatous_polyposis_1|Familial adenomatous polyposis 1]] | ||
|Disease | |Disease | ||
− | | | + | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
|- | |- | ||
|[[CNS5:Naevoid_basal_cell_carcinoma_syndrome|Naevoid basal cell carcinoma syndrome]] | |[[CNS5:Naevoid_basal_cell_carcinoma_syndrome|Naevoid basal cell carcinoma syndrome]] | ||
Line 1,273: | Line 1,533: | ||
|[[CNS5:DICER1_syndrome|DICER1 syndrome]] | |[[CNS5:DICER1_syndrome|DICER1 syndrome]] | ||
|Disease | |Disease | ||
− | | | + | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
|- | |- | ||
|[[CNS5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]] | |[[CNS5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]] | ||
Line 1,328: | Line 1,588: | ||
|[[CNS5:Fanconi_anaemia|Fanconi anaemia]] | |[[CNS5:Fanconi_anaemia|Fanconi anaemia]] | ||
|Disease | |Disease | ||
− | | | + | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
|- | |- | ||
|[[CNS5:ELP1-medulloblastoma_syndrome|ELP1-medulloblastoma syndrome]] | |[[CNS5:ELP1-medulloblastoma_syndrome|ELP1-medulloblastoma syndrome]] |
Revision as of 16:04, 30 July 2024
Welcome!
For assignments, please see the "Author" column below (highlighted blue).
If empty (no name is present), please volunteer to create content for that disease!
To volunteer, please [Contact us] with your page of interest.